Galmed Pharmaceuticals
GLMD
#10244
Rank
NZ$6.06 M
Marketcap
$2.68
Share price
-1.23%
Change (1 day)
-66.81%
Change (1 year)

EPS for Galmed Pharmaceuticals (GLMD)

EPS in 2023 (TTM): -$11.15

According to Galmed Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$11.22. In 2022 the company made an earnings per share (EPS) of -$17.73 an increase over its 2021 EPS that were of -$33.22.

EPS history for Galmed Pharmaceuticals from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$11.15-37.11%
2022-$17.73-46.62%
2021-$33.22-2.22%
2020-$33.9739.18%
2019-$24.4170.18%
2018-$14.34-41.84%
2017-$24.66-34.23%
2016-$37.4956.84%
2015-$23.919.2%
2014-$21.89-53.43%
2013-$47.01

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.16-80.72%๐Ÿ‡บ๐Ÿ‡ธ USA
-$6.74-39.91%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
-$1.26-88.79%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.96-64.72%๐Ÿ‡บ๐Ÿ‡ธ USA